Previously, we showed that necrosis, HIF-1α and CA9 but not Glut-1 or a 26-gene head and neck signature predicted benefit from the addition of CON to RT in patients with bladder cancer (Eustace et al, 2013a, 2013b; Hunter et al, 2014). The gene discussed is HIF1A; the disease is urinary bladder carcinoma.